Association between Laboratory Findings and Mortality of Hospitalized Patients with Covid-۱۹ in Mashhad, Iran
Publish Year: 1401
نوع سند: مقاله ژورنالی
زبان: English
View: 147
This Paper With 17 Page And PDF Format Ready To Download
- Certificate
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_ZUMS-30-143_008
تاریخ نمایه سازی: 7 آبان 1401
Abstract:
Background and Objective: COVID-۱۹ has enforced high burden on health systems universally. To better allocate limited health equipment, we aimed to investigate the prognostic impacts of laboratory parameters.
Materials and Methods: All SARS-CoV-۲ patients admitted to Imam-Reza University Hospital, Mashhad, Iran, during three COVID۱۹ peak periods in Iran (March to April ۲۰۲۰, July to August, and October to November ۲۰۲۰) were enrolled the study. Demographic and laboratory data were extracted and compared between survivors and non-survivors. Regression analyses and receiver operating characteristic (ROC curve) were used to identify risk factors and assess the ability of laboratory tests in predicting in-hospital mortality.
Results: A total of ۲۱۵۶ COVID۱۹ patients were included in the analysis, with a mean age of ۶۰.۲۰ (±۱۸.۸) years. Most patients were male (۵۷%). Multiple regression analysis identified older age (OR=۱.۰۱), male sex (OR=۲.۳۴), lymphopenia (OR=۲.۱۲), LDH >۵۰۰U/L (OR=۲.۱۷), hypernatremia (OR=۹.۷), urea >۴۵mg/dL (OR=۳.۶), and BS >۲۰۰mg/dl (OR=۱.۹۳) as significant risk factors for in-hospital death. Using ROC curve analysis, D-dimer (>۱۰۰۰ng/ml) as well as CK-Mb (>۲۸U/L) both with sensitivities and specificities of more than ۸۰% and PPV of about ۹۰% were able to identify patients with higher possibility of in-hospital death.
Conclusion: Male sex, older age, lymphopenia, hypernatremia, increased Urea, increased LDH, and hyperglycemia may serve as potential risk factors for in-hospital death. D-dimer and CK-MB may be used in identifying patients with high probability of in-hospital death. These tests may be used in clinical decision-making in order to improve outcomes of patients with COVID-۱۹.
Keywords:
Authors
Zahra Khoshnegah
Dept. of Hematology and Blood Banking, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
Mohammad Reza Keramati
Dept. of Hematology and Blood Banking, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
Shirin Taraz Jamshidi
Dept. of Pathology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
Mehdi Karimi-Shahri
Dept. of Pathology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
Samaneh Boroumand-Noughabi
Dept. of Hematology and Blood Banking, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
مراجع و منابع این Paper:
لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :